McKesson Cost of Goods Sold 2010-2024 | MCK

McKesson annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • McKesson cost of goods sold for the quarter ending June 30, 2024 was $76.131B, a 6.54% increase year-over-year.
  • McKesson cost of goods sold for the twelve months ending June 30, 2024 was $300.793B, a 10.71% increase year-over-year.
  • McKesson annual cost of goods sold for 2024 was $296.123B, a 12.02% increase from 2023.
  • McKesson annual cost of goods sold for 2023 was $264.353B, a 5.39% increase from 2022.
  • McKesson annual cost of goods sold for 2022 was $250.836B, a 10.95% increase from 2021.
McKesson Annual Cost of Goods Sold
(Millions of US $)
2024 $296,123
2023 $264,353
2022 $250,836
2021 $226,080
2020 $219,028
2019 $202,565
2018 $197,173
2017 $187,262
2016 $179,468
2015 $167,634
2014 $129,040
2013 $115,315
2012 $115,919
2011 $106,114
2010 $103,026
2009 $101,254
McKesson Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $76,131
2024-03-31 $72,770
2023-12-31 $77,746
2023-09-30 $74,146
2023-06-30 $71,461
2023-03-31 $65,844
2022-12-31 $67,316
2022-09-30 $67,062
2022-06-30 $64,131
2022-03-31 $62,784
2021-12-31 $65,186
2021-09-30 $63,224
2021-06-30 $59,642
2021-03-31 $55,845
2020-12-31 $59,448
2020-09-30 $57,808
2020-06-30 $52,979
2020-03-31 $55,199
2019-12-31 $56,139
2019-09-30 $54,749
2019-06-30 $52,941
2019-03-31 $49,228
2018-12-31 $53,238
2018-09-30 $50,271
2018-06-30 $49,828
2018-03-31 $48,553
2017-12-31 $50,902
2017-09-30 $49,227
2017-06-30 $48,491
2017-03-31 $45,917
2016-12-31 $47,318
2016-09-30 $47,201
2016-06-30 $46,826
2016-03-31 $43,826
2015-12-31 $45,027
2015-09-30 $45,917
2015-06-30 $44,698
2015-03-31 $42,008
2014-12-31 $43,586
2014-09-30 $41,296
2014-06-30 $40,744
2014-03-31 $35,281
2013-12-31 $32,486
2013-09-30 $30,964
2013-06-30 $30,309
2013-03-31 $28,651
2012-12-31 $29,454
2012-09-30 $28,072
2012-06-30 $29,138
2012-03-31 $29,606
2011-12-31 $29,273
2011-09-30 $28,569
2011-06-30 $28,471
2011-03-31 $27,102
2010-12-31 $26,786
2010-09-30 $26,168
2010-06-30 $26,058
2010-03-31 $25,060
2009-12-31 $26,817
2009-09-30 $25,795
2009-06-30 $25,354
2009-03-31 $24,759
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.143B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74